Long Term Outcomes for Basal Cell Carcinoma Treated with Vismodegib Extended Alternate Day Dosing Main Article Content Ethan Routt Keywords Abstract Not available. Article Sidebar Full Article PDF Published Mar 11, 2019 DOI https://doi.org/10.25251/skin.3.2.32 Article Details How to Cite Routt, E. (2019). Long Term Outcomes for Basal Cell Carcinoma Treated with Vismodegib Extended Alternate Day Dosing. SKIN The Journal of Cutaneous Medicine, 3(2), 150-151. https://doi.org/10.25251/skin.3.2.32 More Citation Formats ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver Issue Vol. 3 No. 2 (2019) Section Rising Derm Stars® Abstracts This work is licensed under a Creative Commons Attribution 4.0 International License. Authors transfer copyright to the publisher as part of the journal publishing agreement.All reprints are subject to the reprint policy.